#prostatecancer pT3a or b??

A super Benjamin Pradere diving into the AI applications for Blasser cancer

AI in citology reading the most impressive, an application already available

European Association of Urology (EAU) #EAU24

Pr Cornford on Gleason 6, nevertheless( I say it as a pathologist) it is still cancer, even if not highly aggressive #prostatecancer #EAU24

Pr Bex with a critical and thoughtful analysis #EAU24 on keynote-564

Admiring Ursula Vogl that she is able to pronounce this without trouble!! #EAU 24

Difficult moment for Benjamin Pradere against Ashish M. Kamat, MD, MBBS in micropap, but he did really well!! #EAU2024

K. Chen and what to do with multiple LG recurrences #EAU2024

Outstanding chairs,rapid fire debate #EAU24 Arnulf Stenzl Ashish M. Kamat, MD, MBBS

Pr Sweeney on M1 PCa

Precurseurs and &, everything about IDC-P George J. Netto MD #USCAP2024

Splitting or lumping together, very interesting talk about RCCs by Michelle_Hirsch (Donovan) #USCAP24

Consensus meeting on sex cord tumors in the testis # USCAP Daniel Berney Andres Martin Acosta (Andy) , both urosocieties present #GUPS and #ISUP

Bladderbiopsie, what do you think? #GUpath

Enfortumab Vedotin + pembro shows broad spectrum of activity for RR PFS and OS in all subgroups. This includes subsets such as lymph node disease, liver mets, PD-L1 status, upper tract disease, platinum eligibility. This +ve data underlines EVP as a new standard of care #GU24

OGNMB congress( Nuclearmedicine) nice talk by @Sandra Heskamp: diff between EBRT and nuclear

You want to learn about prostate cancer ? No better place to go: APCCC 2024 in Lugano! Register here ! apccc.org Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin Axel S. Merseburger Derya Tilki, MD prof. Stefano Fanti Michael Hofman

Merry Christmas and thanks to all my followers for your trust!!

Putting things right silke gillessen #myESMO

Difficult task for Ken Herrmann , but hot topic on monitoring of mCSPC #myESMO

Pr Karim Fizazi approach on mCSPC #myESMO